Empirical versus preemptive antimycotic therapy in terms of outcome benefit

Podobne zapisy

• Efficacy and utility of preemptive anti-Gr(+) coverage in selected critically ill patients
  od: Todorova, VT, i wsp.
  Wydane: (2013)
• Efficacy and utility of a protocol for pre-emptive antimycotic therapy
  od: Milanov, SG, i wsp.
  Wydane: (2010)
• Fungal infections in the intensive care unit? Another approach for defining a target group of patients who benefit from implementing preemptive antimycotic treatment
  od: Geube, M, i wsp.
  Wydane: (2007)
• Determinants of ventilator weaning outcome in a medical-surgical ICU
  od: Georgiev, G, i wsp.
  Wydane: (2014)
• Gram-positive nosocomial infections in a general ICU: emerging new clues
  od: Milanov, S, i wsp.
  Wydane: (2011)